Expression of Cholinesterase in Bone Tumors, Blood and Cord Blood
Article Sidebar
Main Article Content
Abstract
The present study aimed to analyze Cholinesterase (CE) levels in cord blood from preeclamptic women and to evaluate cholinesterase status in patients with osteosarcoma. Serum cholinesterase levels were assessed in 30 cases of osteosarcoma and 30 controls suffering from musculoskeletal pain. Additionally, maternal and cord blood samples were collected from 25 women with preeclampsia and compared with those from 25 normotensive pregnant women and 25 normal, healthy controls. The results indicated that serum cholinesterase levels were significantly lower in osteosarcoma patients (Group I) compared to those with musculoskeletal pain (Group II, p < 0.05). Similarly, cholinesterase levels were reduced in the maternal blood of women with preeclampsia when compared to normotensive controls. Cord blood cholinesterase levels were lower in the infants of normotensive mothers, with levels reaching 88.65% of the maternal levels. Furthermore, cord blood cholinesterase levels were significantly lower in preeclamptic women compared to normotensive pregnant women. When comparing cholinesterase levels to those of normal controls, it was observed that CE levels were significantly elevated in both normotensive and preeclamptic women. The findings of low serum cholinesterase levels in this study suggest that cholinesterase secreted by osteoblasts is utilized in bone formation and tumorigenesis. Additionally, the decrease in cholinesterase levels associated with preeclampsia may be linked to the loss of muscarinic cholinergic receptors that occur in this condition.
Article Details
Copyright (c) 2024 Kharb S, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Kawashima K, Fujii T. Basic and clinical aspects of non-neuronal acetylcholine: Overview of non-neuronal cholinergic systems and their biological significance. J Pharmacol Sci. 2008;106:167-173. Available from: https://doi.org/10.1254/jphs.fm0070073
Garcia SC, Wyse AT, Valentini J, Roehrs M, Moro AM, Paniz C, Schmitt G, Grotto D, Pomblum VJ. Butyrylcholinesterase activity is reduced in haemodialysis patients: is there association with hyperhomocysteinemia and/or oxidative stress? Clin Biochem. 2008;41(7-8):474-9. Available from: https://doi.org/10.1016/j.clinbiochem.2008.01.005
Bessmel'tsev SS, Rybakova LP, Gritskevich NL, Golota GZ, Blinov MN, Abdulkadyrov KM. Diagnostic and prognostic significance of blood-serum ceruloplasmin, acetylcholinesterase and total proteolytic activity in patients with multiple myeloma. Vopr Onkol. 1999;45:398-404. Available from: https://pubmed.ncbi.nlm.nih.gov/10532099/
Chougule A, Hussain S, Agarwal DP. Prognostic and diagnostic value of serum pseudocholinesterase, serum aspartate transaminase, and serum alanine transaminase in malignancies treated by radiotherapy. J Cancer Res Ther. 2008;4:21-5. Available from: https://doi.org/10.4103/0973-1482.39601
Grisaru D, Lev-Lehman E, Shapira M, Chaikin E, Lessing JB, Eldor A, et al. Human osteogenesis involves differentiation-dependent increases in the morphogenically-active 3’alternative splicing variant of acetylcholinesterase. Mol Cell Biol. 1999;19:788-95. Available from: https://doi.org/10.1128/mcb.19.1.788
Genever PG, Birch MA, Brown E, Skerry TM. Osteoblast-derived acetylcholinesterase: a novel mediator of cell-matrix interactions in bone? Bone. 1999;24:297-303. Available from: https://doi.org/10.1016/s8756-3282(98)00187-2
Ness RB and Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006;195:40-49. Available from: https://doi.org/10.1016/j.ajog.2005.07.049
Gluckman PD and Brinsmead MW. Somatomedin in cord blood: relationship to gestational age and birth size. J Clin Endocrinol Metab. 1976;43:1378-81. Available from: https://doi.org/10.1210/jcem-43-6-1378
Burkhardt T, Matter CM, Lohmann C, Cai H, Luscher TF, Zisch AH, et al. Decreased umbilical artery compliance and igf-I plasma levels in infants with intrauterine growth restriction - implications for fetal programming of hypertension. Placenta. 2009;30:136-141. Available from: https://doi.org/10.1016/j.placenta.2008.11.005
Baker J, Liu JP, Robertson EJ and Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993;75:73-82. Available from: https://pubmed.ncbi.nlm.nih.gov/8402902/
Sferruzzi-Perri AN, Owens JA, Pringle KG, Robinson JS, Roberts CT. Maternal insulin-like growth factors I and -II act via different pathways to promote fetal growth. Endocrinol. 2006;147:3344-55. Available from: https://doi.org/10.1210/en.2005-1328
Proposal of standard methods for the determination of enzyme catalytic concentrations in serum and plasma at 37 degrees C.II. Cholinesterase (acylcholine acylhydrolase, EC 3.1.1.8).Working Group of enzymes, German Society for Clinical Chemistry. Eur J Clin Biochem. 1992;303:163-70. Available from: https://pubmed.ncbi.nlm.nih.gov/1599981/
Kawashima K, Fujii T. Basic and clinical aspects of non-neuronal acetylcholine: Overview of non-neuronal cholinergic systems and their biological significance. J Pharmacol Sci. 2008;106:167-173. Available from: https://doi.org/10.1254/jphs.fm0070073
Rothem DE, Rothem L, Dahan A, Eliakim R, Soudry M. Nicotinic modulation of gene expression in osteoblast cells, MG-63. Bone. 2011;48:903-9. Available from: https://doi.org/10.1016/j.bone.2010.12.007
Tsakiris S, Schulpis KH, Papaconstantinou ED, Tsakiris T, Tjamouranis I, Giannoulia-Karanatana A. Erytrocyte membrane acetylcholinesterase activity in subjects with MTHFR 677CàT genotype. Clin Chem Lab Med. 2006;441:23-7. Available from: https://doi.org/10.1515/cclm.2006.005
Bessmel'tsev SS, Rybakova LP, Gritskevich NL, Golota GZ, Blinov MN, Abdulkadyrov KM. Diagnostic and prognostic significance of blood-serum ceruloplasmin, acetylcholinesterase and total proteolytic activity in patients with multiple myeloma. Vopr Onkol. 1999;45:398-404. Available from: https://pubmed.ncbi.nlm.nih.gov/10532099/
Howard JK, East NJ, Chaney JL. Plasma cholinesterase activity in early pregnancy. Arch Environ Health. 1978;33: 277-79. Available from: https://doi.org/10.1080/00039896.1978.10667347
Nosse ME, Hartmann S, Trinkaus K, Alt V, Stigler B, Heiss C, et al. Expression of the non-neuronal cholinergic system in osteoblast-like cells and its involvement in osteogenesis. Cell and Tissue Research. 2009;338:45-7. Available from: https://doi.org/10.1007/s00441-009-0871-1
Wessler I, Kirkpatrick C J. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol. 2008;154:1558–71. Available from: https://doi.org/10.1038/bjp.2008.185
Evans RT, O’Callaghan J, Norman A. A longitudinal study of cholinesterase changes in pregnancy. Clin Chem. 1988; 34:2249-52. Available from: https://pubmed.ncbi.nlm.nih.gov/3180418/
De Peyster A, Willis WO, Liebhaber M. Cholinesterase activity in pregnant women and newborns. J Toxicol Clin Toxicol. 1994;32:683-96. Available from: https://doi.org/10.3109/15563659409017975
Kambam JR, Mouton S, Entman S, Sastry BV, Smith BE. Effect of preeclampsia on plasma cholinesterase activity. Can J Anaesth. 1987;34:509-11. Available from: https://doi.org/10.1007/bf03014359
Prichard JA. Plasma cholinesterase activity in normal pregnancy and clastogenic toxaemias. Am J Obstet Gynecol. 1955;70: 1083. Available from: https://doi.org/10.1016/0002-9378(55)90017-x
Harma M, Harma M, Verit F, Kafali H, Artuc H, Demir N. Plasma cholinesterase levels in non-pregnant, normal pregnant and preeclamptic patients. Hr U Tip Fak Der. 2004:2. Available from: https://web.harran.edu.tr/assets/uploads/sites/232/arsiv/200412_2.pdf
Weinstein L. Preeclampsia/eclampsia with hemolysis, elevated liver enzymes and thrombocytopenia. Obstet Gynecol. 1985;66: 657-60. Available from: https://pubmed.ncbi.nlm.nih.gov/4058824/
Areekul S, Srichairat S, Churdchu K, Yamarat P. Red cell and serum cholinesterase activities in adult and cord blood. J Med Ass Thailand. 1981;64:510-3. Available from: https://pubmed.ncbi.nlm.nih.gov/7256362/
Paparini, D, Gori S, Grasso E, Scordo W, Calo G, Pérez Leirós C, et al. Acetylcholine contributes to the control of the physiological inflammatory response during the peri-implantation period. Acta Physiol. 2015;214:237–47. Available from: https://doi.org/10.1111/apha.12494
Jiang X, Bar HY, Yan J, Jones S, Brannon PM, West AA, et al. A higher maternal choline intake among third-trimester pregnant women lowers placental and circulating concentrations of the antiangiogenic factor fms-like tyrosine kinase-1 (sFLT1). FASEB J. 2013;27:1245- 53. Available from: https://doi.org/10.1096/fj.12-221648
Kharb S, Panjeta P, Kala V, Ghalaut VS, Bala J, Nanda S. Cholinesterase levels in cord blood in preeclamptics. J Cardiovasc Disease Res. 2018;9:156-159. Available from: https://pdfs.semanticscholar.org/8aac/fac470bf7838adfa2c5b54dc4dfb01c06b2d.pdf
Mohammad FK, Mohammed AA, Garmavy HM, Rashid HM. Association of reduced maternal plasma cholinesterase activity with preeclampsia: a meta-analysis. Cureus. 2023;15(10):e47220. Available from: https://doi.org/10.7759/cureus.47220
Chen J, Cheuk IWY, Shin VY, Kwong A. Acetylcholine receptors: Key players in cancer development. Surg Oncol. 2019;31:46-53. Available from: https://doi.org/10.1016/j.suronc.2019.09.003
Pérez-Aguilar B, Marquardt JU, Muñoz-Delgado E, López-Durán RM, Gutiérrez-Ruiz MC, Gomez-Quiroz LE, et al. Changes in the acetylcholinesterase enzymatic activity in tumor development and progression. Cancers. 2023; 15(18):4629. Available from:https://www.mdpi.com/2072-6694/15/18/4629
Richbart, SD, Merritt JC, Nolan NA, Dasgupta P. Acetylcholinesterase and human cancers. Adv Cancer Res. 2021; 152:1-66. Available from: https://doi.org/10.1016/bs.acr.2021.05.001